canaccord adams
-
Recon
Obesity, the next big thing in medical devices
Written By: William Plovanic Eighty-four million adults in the US struggle with obesity: The prevalence of obesity as a percentage of…
Read More » -
Spine
JURY FINDS NUVASIVE INFRINGES 3 MEDTRONIC PATENTS, AWARDS MEDTRONIC $101.2M IN DAMAGES; MAINTAIN HOLD AND $22.50 PT
JURY FINDS NUVASIVE INFRINGES 3 MEDTRONIC PATENTS, AWARDS MEDTRONIC $101.2M IN DAMAGES; MAINTAIN HOLD AND $22.50 PT Click Here for…
Read More » -
STRYKER TO PRESENT AT INVESTOR CONFERENCE
Stryker Corporationannounced today that it will participate in the following investor conference: March 9, 2010 - 3:20 p.m. Central Time…
Read More » -
Osteotech to Present at the Canaccord Adams Musculoskeletal Conference
EATONTOWN, N.J., March 3 /PRNewswire-FirstCall/ — Osteotech, Inc. (Nasdaq: OSTE), a leader in the emerging field of biologic products for regenerative healing, announced…
Read More » -
NeuroMetrix to Present at the Canaccord Adams Musculoskeletal Conference
WALTHAM, Mass., Mar 02, 2010 (BUSINESS WIRE) — NeuroMetrix, Inc. (NURO 2.08, -0.02, -0.95%), a health care company transforming patient care through neurotechnology,…
Read More » -
Advanced BioHealing to Present at Canaccord Adams Musculoskeletal Conference
WESTPORT, Conn.–(BUSINESS WIRE)–Advanced BioHealing, Inc. (ABH), a leader in commercializing the promise of regenerative medicine, announced that Vice President and Chief…
Read More » -
Stryker to Present at Investor Conference
KALAMAZOO, Mich., March 1 /PRNewswire/ — Stryker Corporation (NYSE: SYK) announced today that it will participate in the following investor conference: March 9,…
Read More » -
Orthovita to Present at the Canaccord Adams Musculoskeletal Conference
MALVERN, Pa.–(BUSINESS WIRE)–Orthovita, Inc. (NASDAQ:VITA), an orthobiologics and biosurgery company, announced today that it will present at the Canaccord Adams…
Read More » -
Canaccord Adams Maintains a ‘Buy’ on NuVasive (NUVA); Q4/09 Results Bring More Questions Than Answers; Guidance Complicated
Canaccord Adams maintains a ‘Buy’ on NuVasive, Inc. (Nasdaq: NUVA), lowers PT from $56.25 to $41. Canaccord analyst says, “The full results…
Read More » -
MAKO Surgical Corp. to Present at the Canaccord Adams Musculoskeletal Conference
FT. LAUDERDALE, Fla., Feb. 23, 2010 (GLOBE NEWSWIRE) — MAKO Surgical Corp. (Nasdaq:MAKO) announced today that Maurice R. Ferre, M.D.,…
Read More » -
ISTO Technologies Inc. to Present at the Canaccord Adams Musculoskeletal Conference
ST. LOUIS, MO–(Marketwire – February 16, 2010) – ISTO Technologies, Inc. announced today that it will participate in the 2010…
Read More »